Moderna (MRNA) Retained Earnings (2017 - 2026)
Moderna (MRNA) reported Retained Earnings of $5.9 billion for Q1 2026, up 58700.0% year-over-year from N/an in Q1 2025, and down 18.59% quarter-over-quarter from $7.2 billion in Q4 2025.
Moderna (MRNA) Retained Earnings (2017 - 2026) Analysis & Trends
Moderna (MRNA) has 10 years of Retained Earnings data on file, last reported at $5.9 billion in Q1 2026.
- Retained Earnings for Q1 2026 came in at $5.9 billion, up 58700.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $5.9 billion (up 58700.0% YoY), and the FY2025 annual result was $7.2 billion, up 72330.0% from the prior year.
- Retained Earnings slipped to $5.9 billion in Q1 2026 per MRNA's latest filing, from $7.2 billion in the prior quarter.
- Over five years, Retained Earnings peaked at $17.0 billion in Q2 2023 and troughed at -$370.0 million in Q4 2022.
- A 5-year average of $6.1 billion and a median of $5.9 billion in 2026 frame the typical range for Retained Earnings.
- The sharpest annual moves came in 2022 and 2025: Retained Earnings slumped 18500.0% in 2022, then jumped 72330.0% in 2025.
- A 5-year view of Retained Earnings shows it stood at -$370.0 million in 2022, then soared by 3777.3% to $13.6 billion in 2023, then tumbled by 100.07% to -$10.0 million in 2024, then jumped by 72330.0% to $7.2 billion in 2025, then slipped by 18.59% to $5.9 billion in 2026.
- Business Quant data shows MRNA's Retained Earnings at $5.9 billion in Q1 2026, $7.2 billion in Q4 2025, and $27.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | -153.89 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -211.85 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.00 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 130.89 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -279.00 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1.88 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 14.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -838.07 Mn |
| 10 | Moderna | 25.27 Bn | 20.06 Bn | -566.00 Mn | 5.88 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.88 Bn |
| Dec 31, 2025 | 7.22 Bn |
| Sep 30, 2025 | 27.00 Mn |
| Jun 30, 2025 | 8.25 Bn |
| Mar 31, 2025 | 10.00 Mn |
| Dec 31, 2024 | -10.00 Mn |
| Sep 30, 2024 | 11.17 Bn |
| Jun 30, 2024 | 11.15 Bn |
| Mar 31, 2024 | -101.00 Mn |
| Dec 31, 2023 | 13.61 Bn |
| Sep 30, 2023 | 13.39 Bn |
| Jun 30, 2023 | 17.02 Bn |
| Mar 31, 2023 | -267.00 Mn |
| Dec 31, 2022 | -370.00 Mn |
| Sep 30, 2022 | 16.86 Bn |
| Jun 30, 2022 | -240.00 Mn |
| Mar 31, 2022 | -184.00 Mn |
| Dec 31, 2021 | -24.00 Mn |
| Sep 30, 2021 | 31.00 Mn |
| Jun 30, 2021 | 1.76 Bn |